标题 |
垂体疾病新型冠状病毒感染临床应对指南
|
网址 | |
DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
其它 |
来源: 中华医学会内分泌学分会 提要: 垂体疾病常伴有内分泌激素紊乱、肿瘤占位效应和多种合并症,新型冠状病毒感染(新冠感染)流行使其管理难度大大增加。因此,本临床应对指南的提出,旨在规范新冠感染期间垂体疾病的临床诊治,加强合并症治疗,为垂体疾病的综合管理提供参考依据和指导意见。 关键词: 新型冠状病毒感染; 垂体疾病; 合并症 Guideline to the clinical management of pituitary diseases during the COVID-19 pandemic. Chinese Society of Endocrinology Summary:Pituitary diseases are often associated with hormonal abnormalities, mass effects and multiple co-morbidities, involving multidisciplinary management and follow-up. The COVID-19 pandemic makes their management much more challenging. Therefore, this clinical guideline aims to standardize the diagnosis and treatment of pituitary diseases and strengthen the management of co-morbidities during the COVID-19 epidemic. Key words:COVID-19; Pituitary disease; co-morbidities 垂体疾病患者常伴有内分泌激素紊乱和肿瘤占位效应,涉及多学科的管理和随访。目前尚无临床证据显示SARS-CoV-2对垂体的直接损伤,但研究表明垂体功能可能存在一定紊乱。相当一部分垂体疾病患者合并垂体功能减退症、糖尿病、高血压、肥胖和心血管疾病等,这些都有可能影响到新冠感染的治疗和管理,带来巨大挑战[1]。为进一步规范新冠感染下垂体疾病的综合管理,本专家团队制订了以下临床应对指南。 |
求助人 | |
下载 |